Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 8.72 CHF 3.81% Market Closed
Market Cap: 359.8m CHF
Have any thoughts about
Medmix Ltd?
Write Note

Medmix Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medmix Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Medmix Ltd
SIX:MEDX
Long-Term Debt
CHf307.5m
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Metall Zug AG
SIX:METN
Long-Term Debt
CHf0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sonova Holding AG
SIX:SOON
Long-Term Debt
CHf1.6B
CAGR 3-Years
13%
CAGR 5-Years
21%
CAGR 10-Years
79%
Medacta Group SA
SIX:MOVE
Long-Term Debt
€146.9m
CAGR 3-Years
23%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Straumann Holding AG
SIX:STMN
Long-Term Debt
CHf383.4m
CAGR 3-Years
-18%
CAGR 5-Years
14%
CAGR 10-Years
N/A
No Stocks Found

Medmix Ltd
Glance View

Market Cap
355.7m CHF
Industry
Health Care

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

MEDX Intrinsic Value
23.96 CHF
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Medmix Ltd's Long-Term Debt?
Long-Term Debt
307.5m CHF

Based on the financial report for Dec 31, 2023, Medmix Ltd's Long-Term Debt amounts to 307.5m CHF.

What is Medmix Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
4%

Over the last year, the Long-Term Debt growth was -1%. The average annual Long-Term Debt growth rates for Medmix Ltd have been 3% over the past three years , 4% over the past five years .

Back to Top